Tpg targets more than $50b raised in 2026 while maintaining 47% full-year FRE margin outlook

OrthoPediatrics projects $265M-$269M 2026 revenue and reiterates ~$25M adjusted EBITDA as it targets 2026 free cash flow break-even

RWR vs. GQRE: Which REIT ETF Is the Better Buy for Investors?

Crexendo targets $100M revenue run rate by end of 2026 while planning volume 46 release in Q2 2027

Rigel projects $285M-$295M 2026 total revenue while preparing mid-august VEPPANU launch